MSD and Gilead scrap Phase III Trodelvy-Keytruda study on lacklustre interim data
Executive Overview In a significant development for the global oncology landscape, pharmaceutical giants MSD (known as Merck & Co. in...
Archive
Tag: gilead
Oncology & Cancer Research
Decoding the Brain’s Weight Loss Switch: Cambridge Researchers Solve the Obesity Drug Paradox
Hematology & Blood Research
Rethinking Quality of Life: Multi-Stakeholder Consensus Calls for Overhaul of Patient-Reported Outcomes in Advanced Blood Cancer Immunotherapies
Bio-Research & Life Sciences
The Golden Corona: Atmospheric Optics, Wildfire Smoke, and Spain’s Rare Low-Horizon Total Solar Eclipse
Medical Devices & Lab Automation
Bridging the Patch Gap: How the Medical Device Industry is Redefining Cybersecurity for Unpatchable Legacy and Long-Life Systems
Clinical Trials & Research
MSD and Gilead scrap Phase III Trodelvy-Keytruda study on lacklustre interim data
Medical Biotechnology
The Deep Freeze Undone: How Arctic Permafrost Carbon is Reshaping Marine Ecosystems and Climate Models
Clinical Trials & Research
PepGen Advances PGN-EDODM1 to Maximum Planned Dose in Phase II FREEDOM2-DM1 Trial Following Favorable Safety Review
Oncology & Cancer Research
Decoding the Immune Landscape: How AI and Blood Antibodies Are Revolutionizing Personalized Vaccination Strategies
Medical Biotechnology
Decoding the Ghost of the Mountains: Whole-Genome Sequencing Reveals South Africa’s Cape Leopards Are a Distinct Evolutionary Lineage
Clinical Trials & Research
Industry Analysts Praise Intismeran’s Landmark Phase II Triumph, Setting Sights on Upcoming Data Readouts
Medical Biotechnology
Unlocking Nature’s Pharmaceutical Factory: How Researchers Cracked the Code of Bacterial Anti-Cancer Drug Synthesis
Oncology & Cancer Research
The Deadly Convergence: How Abdominal Fat and Vitamin D Deficiency Compound Health Risks After 50
